Palvella Therapeutics (PVLA) AGM 2026 summary

Opening remarks and agenda

• Meeting conducted virtually to maximize stockholder participation and accessibility.

• Agenda and rules of conduct were adopted and made available on the virtual meeting site.

• Chairman, board members, and independent auditor were introduced; meeting officially called to order.

Board and executive committee updates

• Quorum confirmed with proxies representing a majority of voting power received.

• Notice of meeting and proxy materials were distributed to stockholders of record.

Shareholder proposals

• Six proposals presented: election of three Class III directors, ratification of auditor, advisory vote on executive compensation, advisory vote on frequency of compensation votes, amendment to equity plan, and potential adjournment.